Type 2 Diabetes Drugs Market Report

China Type 2 Diabetes Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：190
  • REPORT CODE：GMM1756439
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Type 2 Diabetes Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Boehringer Ingelheim International GmbH

    • Sanofi SA

    • Novartis AG

    • Novo Nordisk AS

    • Takeda Pharmaceutical Co Ltd

    • Daiichi Sankyo Co Ltd

    • Amgen Inc

    • AstraZeneca PLC

    • Eli Lilly and Co

    By Type:

    • Metformin

    • Other

    • Thiazolidinediones

    • Sulfonylureas

    • Meglitinides

    By Application:

    • Retail and Online Pharmacy

    • Hospital Pharmacy

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Type 2 Diabetes Drugs Market Overview 2018-2029

    • 1.1 China Type 2 Diabetes Drugs Industry Development Overview

    • 1.2 China Type 2 Diabetes Drugs Industry Development History

    • 1.3 China Type 2 Diabetes Drugs Industry Market Size (2018-2029)

    • 1.4 China Type 2 Diabetes Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Metformin (2018-2029)

      • 1.4.2 China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.3 China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Thiazolidinediones (2018-2029)

      • 1.4.4 China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Sulfonylureas (2018-2029)

      • 1.4.5 China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Meglitinides (2018-2029)

    • 1.5 China Type 2 Diabetes Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Type 2 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Retail and Online Pharmacy (2018-2029)

      • 1.5.2 China Type 2 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)

    • 1.6 China Type 2 Diabetes Drugs Market Analysis by Region

      • 1.6.1 North China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Type 2 Diabetes Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Type 2 Diabetes Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Type 2 Diabetes Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Type 2 Diabetes Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Type 2 Diabetes Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Type 2 Diabetes Drugs Industry Development

    Chapter 3 Type 2 Diabetes DrugsIndustry Chain Analysis

    • 3.1 Type 2 Diabetes Drugs Industry Chain

    • 3.2 Type 2 Diabetes Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Type 2 Diabetes Drugs Market

    • 3.3 Type 2 Diabetes Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Type 2 Diabetes Drugs Market

    Chapter 4 China Type 2 Diabetes Drugs Market, by Type

    • 4.1 China Type 2 Diabetes Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Type 2 Diabetes Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Type 2 Diabetes Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Type 2 Diabetes Drugs Production Volume and Growth Rate of Metformin

      • 4.5.2 China Type 2 Diabetes Drugs Production Volume and Growth Rate of Other

      • 4.5.3 China Type 2 Diabetes Drugs Production Volume and Growth Rate of Thiazolidinediones

      • 4.5.4 China Type 2 Diabetes Drugs Production Volume and Growth Rate of Sulfonylureas

      • 4.5.5 China Type 2 Diabetes Drugs Production Volume and Growth Rate of Meglitinides

    Chapter 5 China Type 2 Diabetes Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Type 2 Diabetes Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Type 2 Diabetes Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Type 2 Diabetes Drugs Market Size and Growth Rate of Retail and Online Pharmacy

      • 5.5.2 China Type 2 Diabetes Drugs Market Size and Growth Rate of Hospital Pharmacy

    Chapter 6 China Type 2 Diabetes Drugs Market, by Region

    • 6.1 China Type 2 Diabetes Drugs Production Volume and Production Value, by Region

    • 6.2 China Type 2 Diabetes Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Type 2 Diabetes Drugs Market Analysis

    • 7.1 North China Type 2 Diabetes Drugs Market, by Type

    • 7.2 North China Type 2 Diabetes Drugs Market, by Application

    Chapter 8 Central China Type 2 Diabetes Drugs Market Analysis

    • 8.1 Central China Type 2 Diabetes Drugs Market, by Type

    • 8.2 Central China Type 2 Diabetes Drugs Market, by Application

    Chapter 9 South China Type 2 Diabetes Drugs Market Analysis

    • 9.1 South China Type 2 Diabetes Drugs Market, by Type

    • 9.2 South China Type 2 Diabetes Drugs Market, by Application

    Chapter 10 East China Type 2 Diabetes Drugs Market Analysis

    • 10.1 East China Type 2 Diabetes Drugs Market, by Type

    • 10.2 East China Type 2 Diabetes Drugs Market, by Application

    Chapter 11 Northeast China Type 2 Diabetes Drugs Market Analysis

    • 11.1 Northeast China Type 2 Diabetes Drugs Market, by Type

    • 11.2 Northeast China Type 2 Diabetes Drugs Market, by Application

    Chapter 12 Southwest China Type 2 Diabetes Drugs Market Analysis

    • 12.1 Southwest China Type 2 Diabetes Drugs Market, by Type

    • 12.2 Southwest China Type 2 Diabetes Drugs Market, by Application

    Chapter 13 Northwest China Type 2 Diabetes Drugs Market Analysis

    • 13.1 Northwest China Type 2 Diabetes Drugs Market, by Type

    • 13.2 Northwest China Type 2 Diabetes Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Boehringer Ingelheim International GmbH

        • 14.1.1 Boehringer Ingelheim International GmbH Company Profile

        • 14.1.2 Boehringer Ingelheim International GmbH Type 2 Diabetes Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sanofi SA

        • 14.2.1 Sanofi SA Company Profile

        • 14.2.2 Sanofi SA Type 2 Diabetes Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Novartis AG

        • 14.3.1 Novartis AG Company Profile

        • 14.3.2 Novartis AG Type 2 Diabetes Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novo Nordisk AS

        • 14.4.1 Novo Nordisk AS Company Profile

        • 14.4.2 Novo Nordisk AS Type 2 Diabetes Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Takeda Pharmaceutical Co Ltd

        • 14.5.1 Takeda Pharmaceutical Co Ltd Company Profile

        • 14.5.2 Takeda Pharmaceutical Co Ltd Type 2 Diabetes Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Daiichi Sankyo Co Ltd

        • 14.6.1 Daiichi Sankyo Co Ltd Company Profile

        • 14.6.2 Daiichi Sankyo Co Ltd Type 2 Diabetes Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Amgen Inc

        • 14.7.1 Amgen Inc Company Profile

        • 14.7.2 Amgen Inc Type 2 Diabetes Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca PLC

        • 14.8.1 AstraZeneca PLC Company Profile

        • 14.8.2 AstraZeneca PLC Type 2 Diabetes Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Eli Lilly and Co

        • 14.9.1 Eli Lilly and Co Company Profile

        • 14.9.2 Eli Lilly and Co Type 2 Diabetes Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Type 2 Diabetes Drugs Industry Research Conclusions

    • 15.2 Type 2 Diabetes Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Type 2 Diabetes Drugs Industry Market Size (2018-2029)

    • Figure China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Metformin (2018-2029)

    • Figure China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Thiazolidinediones (2018-2029)

    • Figure China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Sulfonylureas (2018-2029)

    • Figure China Type 2 Diabetes Drugs Production Volume, Production Value and Growth Rate of Meglitinides (2018-2029)

    • Figure China Type 2 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Retail and Online Pharmacy (2018-2029)

    • Figure China Type 2 Diabetes Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)

    • Figure North China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Type 2 Diabetes Drugs Market Size and Growth Rate from 2018-2029

    • Figure Type 2 Diabetes Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Type 2 Diabetes Drugs Market Share by Type in 2018

    • Figure China Type 2 Diabetes Drugs Market Share by Type in 2023

    • Figure China Type 2 Diabetes Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Type 2 Diabetes Drugs Production Volume and Growth Rate of Metformin (2018-2023)

    • Figure China Type 2 Diabetes Drugs Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Type 2 Diabetes Drugs Production Volume and Growth Rate of Thiazolidinediones (2018-2023)

    • Figure China Type 2 Diabetes Drugs Production Volume and Growth Rate of Sulfonylureas (2018-2023)

    • Figure China Type 2 Diabetes Drugs Production Volume and Growth Rate of Meglitinides (2018-2023)

    • Figure China Type 2 Diabetes Drugs Market Share by Application in 2018

    • Figure China Type 2 Diabetes Drugs Market Share by Application in 2023

    • Figure China Type 2 Diabetes Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Type 2 Diabetes Drugs Market Size and Growth Rate of Retail and Online Pharmacy (2018-2023)

    • Figure China Type 2 Diabetes Drugs Market Size and Growth Rate of Hospital Pharmacy (2018-2023)

    • Table China Type 2 Diabetes Drugs Production Volume by Region (2018-2023)

    • Table China Type 2 Diabetes Drugs Production Volume Share by Region (2018-2023)

    • Figure China Type 2 Diabetes Drugs Production Volume Share by Region (2018-2023)

    • Table China Type 2 Diabetes Drugs Production Value by Region (2018-2023)

    • Table China Type 2 Diabetes Drugs Production Value Share by Region (2018-2023)

    • Figure China Type 2 Diabetes Drugs Production Value Share by Region (2018-2023)

    • Table China Type 2 Diabetes Drugs Sales Volume by Region (2018-2023)

    • Table China Type 2 Diabetes Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Type 2 Diabetes Drugs Sales Volume Share by Region (2018-2023)

    • Table China Type 2 Diabetes Drugs Sales Value by Region (2018-2023)

    • Table China Type 2 Diabetes Drugs Sales Value Share by Region (2018-2023)

    • Figure China Type 2 Diabetes Drugs Sales Value Share by Region (2018-2023)

    • Table North China Type 2 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table North China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table North China Type 2 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table North China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Type 2 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Central China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Type 2 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Central China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Type 2 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table South China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table South China Type 2 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table South China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Type 2 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table East China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table East China Type 2 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table East China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Type 2 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Type 2 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Type 2 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Type 2 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Type 2 Diabetes Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Type 2 Diabetes Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Type 2 Diabetes Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Type 2 Diabetes Drugs Sales Volume Share by Application (2018-2023)

    • Table Boehringer Ingelheim International GmbH Company Profile

    • Table Boehringer Ingelheim International GmbH Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk AS Company Profile

    • Table Novo Nordisk AS Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Co Ltd Company Profile

    • Table Takeda Pharmaceutical Co Ltd Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Co Ltd Company Profile

    • Table Daiichi Sankyo Co Ltd Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca PLC Company Profile

    • Table AstraZeneca PLC Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Co Company Profile

    • Table Eli Lilly and Co Type 2 Diabetes Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US